What Fueled The Previous Growth In The Anti Inflammatory Therapeutics Market?
The anti inflammatory therapeutics market has seen considerable growth due to a variety of factors.
• In recent years, the market size for anti-inflammatory therapeutics has seen consistent growth. It is projected to rise from $114.71 billion in 2024 to $118.44 billion in 2025, with a compound annual growth rate of 3.3%.
The growth seen in the historical period is attributed to factors such as the prevalence of chronic diseases, aging population, heightened awareness, and government initiatives.
What Can Be Expected from the Anti Inflammatory Therapeutics Market Size?
The anti inflammatory therapeutics market is expected to maintain its strong growth trajectory in upcoming years.
• It is anticipated that the anti-inflammatory therapeutics market will experience significant expansion in the coming years. The market is projected to reach $144.05 billion by 2029, with a compound annual growth rate (CAGR) of 5.0%.
The growth during this forecast period can be credited to innovative therapies, a surge in healthcare spending, attention to rare diseases, and the development of biologics and biosimilars. The forecast period is also expected to witness major trends such as advancements in immunotherapy, the application of artificial intelligence (AI) and machine learning (ML) in drug discovery, and the broadening of indications.
What Are the Critical Driver Fuelling The Anti Inflammatory Therapeutics Market's Growth?
The anticipated growth of the anti-inflammatory therapeutics market is attributed to the rising prevalence of inflammatory bowel disease. This chronic condition results in gastrointestinal tract inflammation, for which anti-inflammatory therapeutics are highly vital. They help mitigate the inflammation, manage disease symptoms, and cut down the risk of surgical intervention. As per the Oxford University Press' July 2023 publication, the University of Oxford's press outlet, the inflammatory bowel disease (IBD) incidence per 100,000 person-years is 10.9, whereas the prevalence stands at 721 per 100,000 people. Thus, the growth of the anti-inflammatory therapeutics market is being spurred by the increasing prevalence of IBD.
Anti-Inflammatory Therapeutics Market Driver: Expected Surge in Autoimmune Disorder Prevalence to Foster Significant Market Growth
How Is The Anti Inflammatory Therapeutics Market segmented?
The anti-inflammatory therapeutics market covered in this report is segmented –
1) By Drug Class: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Anti-Inflammatory Biologics
2) By Indication: Arthritis, Respiratory Diseases, Multiple Sclerosis, Psoriasis, Inflammatory Bowel Diseases, Other Inflammatory Diseases
3) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Distribution
Subsegments:
1) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Ibuprofen, Aspirin, Naproxen, Diclofenac, Celecoxib, Indomethacin, Ketoprofen
2) By Corticosteroids: Prednisone, Dexamethasone, Hydrocortisone, Methylprednisolone, Triamcinolone, Betamethasone
3) By Anti-Inflammatory Biologics: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin Inhibitors, Janus Kinase (JAK) Inhibitors, Monoclonal Antibodies, Recombinant Proteins, Fusion Proteins
Pre-Book The Anti Inflammatory Therapeutics Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends Are Shaping The Anti Inflammatory Therapeutics Market?
Leading companies in the anti-inflammatory therapeutics market are launching novel medications to solidify their market standing. An example of this is Regeneron Pharmaceuticals Inc., an American biotechnology firm, and Sanofi, a French pharmaceutical and healthcare organization, which introduced Kevzara (sarilumab) in February 2023. This anti-inflammatory biologic, the only one of its kind, is advised for adults suffering from polymyalgia rheumatic (PMR), a type of inflammatory rheumatic disease, who do not adequately react to corticosteroids or cannot handle corticosteroid tapering.
Who Are the Key Players In The Anti Inflammatory Therapeutics Market?
Major companies operating in the anti-inflammatory therapeutics market are:
• Pfizer Inc.
• Johnson and Johnson Limited
• F. Hoffmann-La Roche Ltd.
• Merck and Co. Inc.
• AbbVie Inc.
• Bayer AG
• Novartis AG
• Sanofi-Aventis LLC.
• Bristol-Myers Squibb Company
• AstraZeneca PLC
• GlaxoSmithKline plc.
• Takeda Pharmaceutical Company Limited
• Eli Lilly and Co Ltd.
• Amgen Inc.
• Boehringer Ingelheim International GmbH
• Viatris Inc.
• Teva Pharmaceutical Industries Ltd.
• Regeneron Pharmaceuticals Inc.
• Astellas Pharma Inc.
• Biogen Inc.
• Daiichi Sankyo Company Limited
• Eisai Co. Ltd.
• Sun Pharmaceutical Industries Limited
• Otsuka Pharmaceutical Co. Ltd.
• Dr. Reddy's Laboratories Ltd.
• Hikma Pharmaceuticals PLC
• Cipla Inc.
• Zydus Lifesciences Ltd.
• Lupin Limited
• Torrent Pharmaceuticals Ltd.
What Is The Most Dominant Region In The Anti Inflammatory Therapeutics Market?
North America was the largest region in the anti-inflammatory therapeutics market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the anti-inflammatory therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
